Hospital/Health-System Pharmacy
Pharmacy groups support expansion of MTM services in Medicare proposal
March 06, 2014By Julia Talsma Content Channel Director
Pharmacy groups, representing more than 100,000 pharmacists in different pharmacy practice settings, have written to CMS Administrator Marilyn B. Tavenner to express their support for the expansion of medication therapy management (MTM) services to Medicare Part D beneficiaries in the CMS proposal released in early January.Stroke prevention in the elderly may be excessive, researcher says
March 03, 2014By Tracey Walker Contributing Editor
Patients more than 80 years old are being “over-treated” for stroke prevention with statins and antihypertensive drugs, and doctors need to actively rethink their priorities and beliefs about stroke prevention, according to a new study published in Evidence Based Medicine.FDA panels vote against OTC Primatene HFA inhaler
March 03, 2014By Julia Talsma Content Channel Director
FDA advisors decided against recommending over-the-counter (OTC) marketing approval of Primatene HFA inhaler (Armstrong Pharmaceuticals) for the temporary relief of mild symptoms of intermittent asthma in patients 12 years and older, at last week’s joint meeting of the FDA’s Nonprescription Drugs Advisory Committee and the Pulmonary-Allergy Drugs Advisory Committee.Advertisement
FDA approves treatment for neurogenic orthostatic hypotension
February 20, 2014By Tracey Walker
FDA approved droxidopa (Northera, Chelsea Therapeutics) capsules for the treatment of neurogenic orthostatic hypotension (NOH). NOH is a rare, chronic and often debilitating condition that is associated with Parkinson's disease, multiple-system atrophy, and pure autonomic failure.New SSRI approved in last quarter of 2013
February 10, 2014By Kevin W. Chamberlin PharmD
FDA approved vortioxetine as oral tablets indicated for the treatment of major depressive disorder.- 1
- 2